BioVentix PLC Director/PDMR Shareholding (0016V)
March 31 2023 - 8:45AM
UK Regulatory
TIDMBVXP
RNS Number : 0016V
BioVentix PLC
31 March 2023
Bioventix plc
("Bioventix" or the "Company")
Director/PDMR Shareholding
Bioventix plc (BVXP), a UK company specialising in the
development and commercial supply of high-affinity monoclonal
antibodies for applications in clinical diagnostics, was notified
on 31 March 2023 of the following transactions in its ordinary
shares of 5 pence each ("Ordinary Shares"):
Director Role Ordinary Average Ordinary Percentage
Shares sale price Shares subsequently of issued
sold per Ordinary held share capital
Share subsequently
held
Ian Nicholson
and Persons Non-Executive
Closely Associated Chairman 2,500 3,900 13,000 0.2%
--------------- --------- -------------- --------------------- ---------------
The notifications below, which have been made in accordance with
the requirements of the Market Abuse Regulation, provide further
details.
For further information please contact:
Bioventix plc Tel: 01252 728 001
Peter Harrison Chief Executive Officer
Bruce Hiscock Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Simon Hicks Corporate Finance
Alice Lane ECM
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Ian Nicholson
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status Chairman
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Bioventix plc
------------------------------- ----------------------------------
b) LEI 213800225MHX7LZQY108
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
------------------------------- ----------------------------------
b) Nature of the transaction Sale of Ordinary Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
3,877p 1,000
----------
------------------------------- ----------------------------------
d) Aggregated information: See 4(c)
* Aggregated volume
* Price
------------------------------- ----------------------------------
e) Date of the transaction 31 March 2023
------------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange, AIM Market
(XLON)
------------------------------- ----------------------------------
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Catherine Nicholson
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status PCA of Ian Nicholson, Chairman
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Bioventix plc
------------------------------- ----------------------------------
b) LEI 213800225MHX7LZQY108
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
------------------------------- ----------------------------------
b) Nature of the transaction Sale of Ordinary Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
3,915p 1,500
----------
------------------------------- ----------------------------------
d) Aggregated information: See 4(c)
* Aggregated volume
* Price
------------------------------- ----------------------------------
e) Date of the transaction 31 March 2023
------------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange, AIM Market
(XLON)
------------------------------- ----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEADDFDLFDEFA
(END) Dow Jones Newswires
March 31, 2023 09:45 ET (13:45 GMT)
Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024
